SEARCH

SEARCH BY CITATION

References

  • Van-Besien, K., Ha, C.S., Murphy, S., McLaughlin, P., Rodriguez, A., Amin, K., Forman, A., Romaguera, J., Hagemeister, F., Younes, A., Bachier, C., Sarris, A., Sobocinski, K.S., Cox, J.D. & Cabanillas, F. (1998) Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood, 91, 11781184.
  • Balis, F.M., Savitch, J.L., Bleyer, W.A., Reaman, G.H. & Poplack, D.G. (1985) Remission induction of meningeal leukemia with high-dose intravenous methotrexate. Journal of Clinical Oncology, 3, 485489.
  • Bashir, R.M., Bierman, P.J., Vose, J.M., Weisenburger, D.D. & Armitage, J.O. (1991) Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma. American Journal of Clinical Oncology, 14, 478482.
  • Batchelor, T., Leahy, N. & Kaufman, D. (2001) High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin's lymphoma. Clinical Lymphoma, 2, 116119.
  • Bishop, P.C., Wilson, W.H., Pearson, D., Janik, J., Jaffe, E.S. & Elwood, P.C. (1999) CNS involvement in primary mediastinal large B-cell lymphoma. Journal of Clinical Oncology, 17, 24792485.
  • Bos, G.M., van Putten, W.L., van der Holt, B., van den Bent, M., Verdonck, L.F. & Hagenbeek, A. (1998) For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group. Annals of Oncology, 9, 191194.
  • Buckstein, R., Lim, W., Franssen, E. & Imrie, K.L. (2003) CNS prophylaxis and treatment in non-Hodgkin's lymphoma: variation in practice and lessons from the literature. Leukaemia and Lymphoma, 44, 955962.
  • Bunn, Jr, P.A., Schein, P.S., Banks, P.M. & DeVita, Jr, V.T. (1976) Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited. Blood, 47, 310.
  • Cetto, G.L., Iannucci, A., Tummarello, D., Rizzuto, N., Sabbioni, R. & Menestrina, F. (1981) Involvement of the central nervous system in non-Hodgkin's lymphoma. Tumori, 67, 3944.
  • Chahal, S., Lagera, J.E., Ryder, J. & Kleinschmidt-DeMasters, B.K. (2003) Hematological neoplasms with first presentation as spinal cord compression syndromes: a 10-year retrospective series and review of the literature. Clinical Neuropathology, 22, 282290.
  • Chua, S.L., Seymour, J.F., Streater, J., Wolf, M.M., Januszewicz, E.H. & Prince, H.M. (2002) Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma. Leukaemia and Lymphoma, 43, 17831788.
  • Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., Reyes, F., Lederlin, P. & Gisselbrecht, C. (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. New England Journal of Medicine, 346, 235242.
  • Cortes, J., O'Brien, S.M., Pierce, S., Keating, M.J., Freireich, E.J. & Kantarjian, H.M. (1995) The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia. Blood, 86, 20912097.
  • Feugier, P., Virion, J.M., Tilly, H., Haioun, C., Marit, G., Macro, M., Bordessoule, D., Recher, C., Blanc, M., Molina, T., Lederlin, P. & Coiffier, B. (2004) Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab. Annals of Oncology, 15, 129133.
  • Fonseca, R., Habermann, T.M., Colgan, J.P., O'Neill, B.P., White, W.L., Witzig, T.E., Egan, K.S., Martenson, J.A., Burgart, L.J. & Inwards, D.J. (2000) Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer, 88, 154161.
  • Gholam, D., Bibeau, F., El Weshi, A., Bosq, J. & Ribrag, V. (2003) Primary breast lymphoma. Leukaemia and Lymphoma, 44, 11731178.
  • Haioun, C., Besson, C., Lepage, E., Thieblemont, C., Simon, D., Rose, C., Tilly, H., Sonet, A., Lederlin, P., Attal, M., Briere, J. & Reyes, F. (2000a) Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'Adulte. Annals of Oncology, 11, 685690.
  • Haioun, C., Lepage, E., Gisselbrecht, C., Salles, G., Coiffier, B., Brice, P., Bosly, A., Morel, P., Nouvel, C., Tilly, H., Lederlin, P., Sebban, C., Briere, J., Gaulard, P. & Reyes, F. (2000b) Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol – a groupe d'Etude des lymphomes de l'Adulte study. Journal of Clinical Oncology, 18, 30253030.
  • Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Mullerhermelink, H.K., Pileri, S.A., Piris, M.A., Ralfkiaer, E. & Warnke, R.A. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 13611392.
  • Hegde, U., Filie, A., Little, R.F., Janik, J.E., Grant, N., Steinberg, S.M., Dunleavy, K., Jaffe, E.S., Abati, A., Stetler-Stevenson, M. & Wilson, W.H. (2005) High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood, 105, 496502.
  • Hoelzer, D. & Gokbuget, N. (2000) New approaches to acute lymphoblastic leukemia in adults: where do we go? Seminars in Oncology, 27, 540559.
  • Hollender, A., Kvaloy, S., Lote, K., Nome, O. & Holte, H. (2000) Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis. European Journal of Cancer, 36, 17621768.
  • Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, JW (2001) WHO Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue. IARC Press, Lyon.
  • Jolivet, J. (1987) Biochemical and pharmacologic rationale for high-dose methotrexate. NCI Monographs, 5, 6165.
  • Keldsen, N., Michalski, W., Bentzen, S.M., Hansen, K.B. & Thorling, K. (1996) Risk factors for central nervous system involvement in non-Hodgkins-lymphoma – a multivariate analysis. Acta Oncologica, 35, 703708.
  • Levitt, L.J., Dawson, D.M., Rosenthal, D.S. & Moloney, W.C. (1980) CNS involvement in the non-Hodgkin's lymphomas. Cancer, 45, 545552.
  • Liang, R., Chiu, E. & Loke, S.L. (1990) Secondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors. Hematological Oncology, 8, 141145.
  • Litam, J.P., Cabanillas, F., Smith, T.L., Bodey, G.P. & Freireich, E.J. (1979) Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxis. Blood, 54, 12491257.
  • MacKintosh, F.R., Colby, T.V., Podolsky, W.J., Burke, J.S., Hoppe, R.T., Rosenfelt, F.P., Rosenberg, S.A. & Kaplan, H.S. (1982) Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases. Cancer, 49, 586595.
  • Magrath, I., Adde, M., Shad, A., Venzon, D., Seibel, N., Gootenberg, J., Neely, J., Arndt, C., Nieder, M., Jaffe, E., Wittes, R.A. & Horak, I.D. (1996) Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. Journal of Clinical Oncology, 14, 925934.
  • Mead, G.M., Sydes, M.R., Walewski, J., Grigg, A., Hatton, C.S., Pescosta, N., Guarnaccia, C., Lewis, M.S., McKendrick, J., Stenning, S.P. & Wright, D. (2002) An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. Annals of Oncology, 13, 12641274.
  • Milpied, N., Deconinck, E., Gaillard, F., Delwail, V., Foussard, C., Berthou, C., Gressin, R., Lucas, V., Colombat, P. & Harousseau, J.L. (2004) Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. New England Journal of Medicine, 350, 12871295.
  • Moreton, P., Morgan, G.J., Gilson, D., Smith, G.M., McVerry, B.A., Davies, J.M., Mackie, M.J., Bolam, S., Jalihal, S.S., Howard, M.R., Parapia, L.A., Williams, A.T. & Child, J.A. (2004) The development of targeted chemotherapy for CNS lymphoma-a pilot study of the IDARAM regimen. Cancer Chemotherapy and Pharmacology, 53, 324328.
  • Pennacchio, L. & Orlandini, M. (1969) Immunoglobulin diseases. (Basis of modern immunology. Clinical contribution. Bing-Neel syndrome). Policlinico Sezione Practica, 76, 401422.
  • Pfreundschuh, M., Trumper, L., Kloess, M., Schmitz, N., Schmits, R., Glass, B., Hasenclever, D., Engert, A., Rudolph, C., Illiger, J., Hossfeld, D., Rube, C., Loeffler, M. & for the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL) (2004a) 2-Weekly CHOP (CHOP14): the new standard regimen for patients with aggressive non-Hodgkins lymphoma (NHL) >60 years of age. Blood, 104, 634641.
  • Pfreundschuh, M., Trumper, L., Kloess, M., Schmits, R., Feller, A.C., Rudolph, C., Reiser, M., Hossfeld, D.K., Metzner, B., Hasenclever, D., Schmitz, N., Glass, B., Rube, C. & Loeffler, M. (2004b) Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL. Blood, 104, 626633.
  • Pinkel, D. & Woo, S. (1994) Prevention and treatment of meningeal leukemia in children. Blood, 84, 355366.
  • Rubenstein, J.L., Combs, D., Rosenberg, J., Levy, A., McDermott, M., Damon, L., Ignoffo, R., Aldape, K., Shen, A., Lee, D., Grillo-Lopez, A. & Shuman, M.A. (2003) Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood, 101, 466468.
  • Shikama, N., Oguchi, M., Sasaki, S., Shinoda, A., Nishikawa, A., Arakawa, K., Koiwai, K., Mochizuki, K., Yamada, A., Watanabe, T. & Kadoya, M. (2001) Evaluation of central nervous system involvement in nasal lymphomas. Nippon Igaku Hoshasen Gakkai Zasshi, 61, 342346.
  • Spevak, J. (1964) The prophylaxis of meningeal leukemia with intrathecal methotrexate. Journal of Iowa Medical Society, 54, 238244.
  • The Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer, 49, 21122135.
  • Tilly, H., Lepage, E., Coiffier, B., Blanc, M., Herbrecht, R., Bosly, A., Attal, M., Fillet, G., Guettier, C., Molina, T.J., Gisselbrecht, C. & Reyes, F. (2003) Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma. Blood, 102, 42844289.
  • Wolf, M.M., Olver, I.N., Ding, J.C., Cooper, I.A., Liew, K.H. & Madigan, J.P. (1985) Non-Hodgkin's lymphoma involving the central nervous system. Australasian and New Zealand Journal of Medicine, 15, 1621.
  • Yamazaki, H., Hanada, M., Kitada, M., Kuyama, J., Sato, T., Nishikubo, M., Ishida, T., Inoue, T. & Inoue, T. (2003) Four cases of central nervous system involvement of breast malignant lymphoma. Japanese Journal of Clinical Oncology, 33, 399403.
  • Zinzani, P.L., Magagnoli, M., Frezza, G., Prologo, G., Gherlinzoni, F., Bendandi, M., Albertini, P., Babini, L., D'Alessandro, R. & Tura, S. (1999) Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience. Leukaemia and Lymphoma, 32, 571576.
  • Zucca, E., Roggero, E., Bertoni, F., Conconi, A. & Cavalli, F. (1999) Primary extranodal non-Hodgkin's lymphomas. Part 2: head and neck, central nervous system and other less common sites. Annals of Oncology, 10, 10231033.
  • Zucca, E., Conconi, A., Mughal, T.I., Sarris, A.H., Seymour, J.F., Vitolo, U., Klasa, R., Ozsahin, M., Mead, G.M., Gianni, M.A., Cortelazzo, S., Ferreri, A.J., Ambrosetti, A., Martelli, M., Thieblemont, C., Moreno, H.G., Pinotti, G., Martinelli, G., Mozzana, R., Grisanti, S., Provencio, M., Balzarotti, M., Laveder, F., Oltean, G., Callea, V., Roy, P., Cavalli, F. & Gospodarowicz, M.K. (2003) Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. Journal of Clinical Oncology, 21, 2027.